Marina Schaaf

Pembrolizumab and maraviroc in refractory mismatch repair proficient/microsatellite-stable metastatic colorectal cancer – The PICCASSO phase I trial

Georg Martin Haag, Christoph Springfeld, Barbara Grün et al. · European Journal of Cancer · 2022 · 95 citations

Medicine, Oncology, Chemotherapy +11

Quality of life and outcome of patients with metastatic pancreatic cancer receiving first‐line chemotherapy with nab‐paclitaxel and gemcitabine: Real‐life results from the prospective <scp>QOLIXANE</scp> trial of the Platform for Outcome, Quality of Life and Translational Research on Pancreatic Cancer registry

Salah‐Eddin Al‐Batran, Ralf‐Dieter Hofheinz, Alexander Reichart et al. · International Journal of Cancer · 2020 · 21 citations · Full text

Medicine, Oncology, Pharmacology +15

Neoadjuvant chemotherapy with gemcitabine plus cisplatin followed by radical liver resection versus immediate radical liver resection alone followed adjuvant therapy in biliary tract cancer: Final results from the phase III AIO/CALGP/ACO-GAIN-Trial.

Thorsten Oliver Goetze, Arndt Vogel, Johann Pratschke et al. · Journal of Clinical Oncology · 2025 · 21 citations

Medicine, Oncology, Surgery +17

Nanoliposomal Irinotecan With Fluorouracil and Leucovorin or Gemcitabine Plus Cisplatin in Advanced Cholangiocarcinoma: A Phase II Study of the AIO Hepatobiliary-YMO Cancer Groups (NIFE-AIO-YMO HEP-0315)

Thomas J. Ettrich, Dominik Paul Modest, Marianne Sinn et al. · Journal of Clinical Oncology · 2024 · 14 citations · Full text

Medicine, Oncology, Pharmacology +14

A soluble LAG-3 protein (eftilagimod alpha) and an anti-PD-L1 antibody (avelumab) tested in a phase I trial: a new combination in immuno-oncology

S-E. Al-Batran, Daniel Mueller, M.-R. Rafiyan et al. · ESMO Open · 2023 · 13 citations · Full text

Pharmacy, Oncology, Pharmacotherapy +17